Skip to main content
. 2015 Feb;6(1):60–74. doi: 10.3978/j.issn.2078-6891.2014.098

Figure 1.

Figure 1

Targeted therapy in gastric cancer and sites of action. VEGFR, vascular endothelial growth factor receptor; EGFR, epidermal growth factor receptor; PI3K, phosphatadylinositol 3-kinase; PTEN, phosphatase and tensin homolog; PDK-1, phosphoinositide-dependent kinase 1; Akt, protein kinase B; mTOR, mammalian target of rapamyin; HGF, hepatocyte growth factor; MEK, mitogen-activated protein/extracellular signal-regulated kinase kinase; ERK, extracellular-regulated kinase.